1.Adult-to-Adult Living Donor Liver Transplantation at the Asan Medical Center.
Yonsei Medical Journal 2004;45(6):1162-1168
Between February 1997 and December 2003, 580 adult-to- adult living donor liver transplants (A-A LDLTs) were performed at the Asan Medical Center for patients above 20 years of age. Indications for A-A LDLT were: chronic hepatitis B (309), chronic hepatitis C (18), hepatocellular carcinoma (144), alcoholic cirrhosis (20), Wilson's disease (4), autoimmune hepatitis (4), hepatic tuberculosis (1), cholangiocarcinoma (2), cryptogenic cirrhosis (5), secondary biliary cirrhosis (7), primary biliary cirrhosis (2), fulminant hepatic failure (18), primary sclerosing cholangitis (2), vanishing bile duct syndrome (1) and re-transplantation (4). Of 580 A-A LDLTs, 119 were of high medical urgency, 96 were for acute on chronic liver failure, 18 were for acute and subacute hepatic failure, 1 was for Wilson's disease, and 4 were for re-transplantation. Recipient age ranged from 20 to 69 years. The age of the donors ranged from 16 to 63 years. There was no donor mortality. Implanted liver grafts were categorized into seven types: 307 modified right lobes (MRL), 85 left lobes, 44 left lobe plus caudate lobes, 41 right lobes, 93 dual grafts, 5 extended right lobes, 4 posterior segments, and 1 extended left lateral segment. In the MRL, the tributaries of the middle hepatic vein were reconstructed by interpositioning a vein graft. Indication for dual graft implantation was the same as single graft A-A LDLT, and seventeen of 93 were emergency cases. As a right-sided graft, 47 received left lobes; 31 received a extended left lateral segment or a lateral segment; 13 received a right lobe with or without the reconstruction of middle hepatic vein tributaries; and 2 received a posterior segment. Graft volume ranged from 26.5% to 83% of the standard liver volume of the recipients. There were 46 (8.0%) one year mortalities among the 576 patients after 580 A-A LDLTs. Of the 119 patients who received emergency transplants, 108 (90.8%) survived. These encouraging results justify the expansion of A-A LDLT to adjust to increasing demands, even in urgent situations. We have aimed establish the efficacy of A-A LDLT in various end-stage chronic and acute liver diseases, as well as new technical advances to overcome the small-for-size graft syndrome by using dual-graft implantation and MRL, both of which were first developed in our department.
Adolescent
;
Adult
;
Humans
;
Korea
;
*Liver Transplantation/methods/mortality/statistics & numerical data
;
*Living Donors
;
Middle Aged
;
Retrospective Studies
;
Survival Analysis
2.Epidemiology and Risk Factors for Bacteremia in 144 Consecutive Living-Donor Liver Transplant Recipients.
Sang Il KIM ; Youn Jeong KIM ; Yoon Hee JUN ; Seong Heon WIE ; Yang Ree KIM ; Jong Young CHOI ; Seung Kyu YOON ; In Sung MOON ; Dong Goo KIM ; Myung Duk LEE ; Moon Won KANG
Yonsei Medical Journal 2009;50(1):112-121
PURPOSE: Bacteremia is a major infectious complication associated with mortality in liver transplant recipients. The causative organisms and clinical courses differ between medical centers due to variations in regional bacterial epidemiology and posttransplant care. Further, living donors in Korea contribute to 83% of liver transplants, and individualized data are required to improve survival rates. PATIENTS AND METHODS: We retrospectively analyzed 104 subjects who had undergone living-donor liver transplant from 2005 to 2007. RESULTS: Among the 144 consecutive living-donor liver transplant recipients, 24% (34/144) developed bacteremia, 32% (46/144) developed non-bacteremic infections, and 44% (64/144) did not develop any infectious complications. Forty episodes of bacteremia occurred in 34 recipients. The major sources of bacteremia were intravascular catheter (30%; 12/40), biliary tract (30%; 12/40), and abdomen (22.5%; 9/40). Gram-positive cocci were more common (57.5%; 23/40) than Gram-negative rods (32.5 %; 13/40) and fungi (10%; 4/40). The data revealed that the following factors were significantly different between the bacteremia, non-bacteremic infection, and no infection groups: age (p = 0.024), posttransplant hemodialysis (p = 0.002), ICU stay (p = 0.012), posttransplant hospitalization (p < 0.0001), and duration of catheterization (p < 0.0001). The risk factors for bacteremia were older than 55 years (odds ratio, 6.1; p = 0.003), catheterization for more than 22 days (odds ratio, 4.0; p = 0.009), UNOS class IIA (odds ratio, 6.6; p = 0.039), and posttransplant hemodialysis (odds ratio, 23.1; p = 0.001). One-year survival rates in the bacteremic, non-bacteremic infection, and no infection groups were 73.2%, 91.3%, and 93.5%, respectively. CONCLUSION: Early catheter removal and preservation of renal function should focus for improving survival after transplant.
Adult
;
Bacteremia/etiology/*mortality
;
Catheterization/adverse effects/statistics & numerical data
;
Female
;
Humans
;
Korea/epidemiology
;
Liver Transplantation/*mortality/statistics & numerical data
;
Living Donors
;
Male
;
Middle Aged
;
Postoperative Complications/etiology/*mortality
;
Predictive Value of Tests
;
Risk Factors
;
Survival Analysis
3.Analysis of survival rate and risk factors of liver retransplantation.
Zhi-Jun ZHU ; Wei RAO ; Hong ZHENG ; Yong-Lin DENG ; Ya-Min ZHANG ; Jian-Jun ZHANG ; Wei GAO ; Cheng PAN ; Wei-Ye ZHANG ; Ming-Sheng HUAI ; Jin-Zhen CAI ; Zhong-Yang SHEN
Chinese Journal of Surgery 2007;45(15):1012-1014
OBJECTIVESTo analyze the survival rate of orthotopic liver retransplantation (Re-OLT) and identify the variables predicting the outcome.
METHODSA retrospective analysis of 74 Re-OLT patients from January 1999 to December 2005 was performed. The univariate analysis of Kaplan-Meier model was used to investigate the relativity between the factors and survival rate, and COX regression model was used in multivariate analysis to identify the prognostic factors for survival.
RESULTSThe total incidence rate of Re-OLT was 5.7%, and overall patient survival rates at 1 month, 3 month, 1 year and 2 year were 82.4%, 73.8%, 71.9% and 68.5%, respectively. There were 10 factors might influence the survival rate by Kaplan-Meier model, such as the period of Re-OLT, stage of hepatic encephalopathy, prothrombin time, total bilirubin, warm ischemia time, operative surgical procedure, quantity of blood lost during operation, days staying in the intensive care unit (ICU), infection and complications after Re-OLT. And three factors among them were identified as independent prognostic factors for survival by multivariate model: operative surgical procedure, days staying in the ICU and complications after Re-OLT.
CONCLUSIONThe surgical procedure, duration in ICU and complications after Re-OLT are strong predictors for survival after Re-OLT.
Adolescent ; Adult ; Female ; Follow-Up Studies ; Humans ; Kaplan-Meier Estimate ; Liver Transplantation ; mortality ; statistics & numerical data ; Male ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proportional Hazards Models ; Reoperation ; mortality ; statistics & numerical data ; Retrospective Studies ; Risk Factors ; Survival Rate
4.Long Term Outcomes of Pediatric Liver Transplantation According to Age.
Jeik BYUN ; Nam Joon YI ; Jeong Moo LEE ; Suk Won SUH ; Tae YOO ; Youngrok CHOI ; Jae Sung KO ; Jeong Kee SEO ; Hyeyoung KIM ; Hae Won LEE ; Hyun Young KIM ; Kwang Woong LEE ; Sung Eun JUNG ; Seong Cheol LEE ; Kwi Won PARK ; Kyung Suk SUH
Journal of Korean Medical Science 2014;29(3):320-327
Liver transplantation (LT) has been the key therapy for end stage liver diseases. However, LT in infancy is still understudied. From 1992 to 2010, 152 children had undergone LT in Seoul National University Hospital. Operations were performed on 43 patients aged less than 12 months (Group A) and 109 patients aged over 12 months (Group B). The mean age of the recipients was 7 months in Group A and 74 months in Group B. The patients' survival rates and post-LT complications were analyzed. The mean Pediatric End-stage Liver Disease score was higher in Group A (21.8) than in Group B (13.4) (P = 0.049). Fulminant hepatitis was less common in Group A (4.8%) than in Group B (13.8%) (P = 0.021). The post-transplant lymphoproliferative disorder and portal vein complication were more common in Group A (14.0%, 18.6%) than in Group B (1.8%, 3.7%) (P = 0.005). However, the 1, 5, and 10 yr patient survival rates were 93%, 93%, and 93%, in Group A and 92%, 90%, and 88% in Group B (P = 0.212). The survival outcome of pediatric LT is excellent and similar regardless of age. LTs in infancy are not riskier than those of children.
Adolescent
;
Age Factors
;
Child
;
Child, Preschool
;
End Stage Liver Disease/mortality/*surgery
;
Female
;
Graft Rejection/epidemiology
;
Graft Survival
;
Herpesviridae Infections/etiology
;
Humans
;
Infant
;
Liver Transplantation/*adverse effects/*statistics & numerical data
;
Lymphoproliferative Disorders/*etiology
;
Male
;
Proportional Hazards Models
;
Risk Factors
;
Severity of Illness Index
;
Survival Rate
;
Treatment Outcome
;
Vascular Diseases/etiology